Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ASX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ASX investment potential.

What is ASX stock price today?

Get real-time ASX stock price, historical data, and price charts on Financhill. Track ASX performance with our advanced analysis tools.

Is ASX a good investment?

Evaluate ASX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ASX stock?

To buy ASX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ASX?

View detailed market capitalization data and company valuation metrics for ASX on our comprehensive analysis page.

What is the P/E ratio of ASX?

Use our fundamental analysis tools to view ASX P/E ratio and compare valuation metrics with industry peers.

What are ASX earnings?

View ASX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

ASE Technology Holding Co., Ltd. 10K Form

Buy

ASX
ASE Technology Holding Co., Ltd.

Last Price:

$15.18

Seasonality Move:

8.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASX News And Ratings

See the #1 stock for the next 7 days that we like better than ASX

ASX Financial Statistics

Sales & Book Value

Annual Sales:	$18.5B
Cash Flow:	$-6.8B
Price / Cash Flow:	67.5
Annual Sales:	$4.78
Price / Book:	3.18

Profitability

EPS (TTM):	0.50230
Net Income (TTM):	$1.2B
Gross Margin:	$2.9B
Return on Equity:	10.97%
Return on Assets:	4.76%

ASE Technology Holding Co., Ltd. Earnings Forecast

Key ASE Technology Holding Co., Ltd. Financial Ratios

The Gross Profit Margin over the past 26 years for ASX is 15.38%.
The Selling, General & Administrative Expenses for ASX have been equal to 4.86% of Gross Profit Margin.
The Research & Development expenses have been 4.84% of Revenue.
The Interest Expense is 19.98% of Operating Income.
The Net Earning history of ASX is 5.70% of Total Revenues.
Per Share Earnings over the last 26 years have been positive in 12 years.

ASE Technology Holding Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Semiconductors & Semiconductor Equipment
Sector:	Information Technology
Current Symbol:	ASX
CUSIP:	00215W
Website:	aseglobal.com

Debt

Debt-to-Equity Ratio:	0.9
Current Ratio:	1.13
Quick Ratio:	0.83

Price-to-Earnings

Trailing P/E Ratio:	33.7
Forward P/E Ratio:	17.62

ASX Technical Analysis vs Fundamental Analysis

Buy

ASE Technology Holding Co., Ltd. (ASX) is a Buy

Is ASE Technology Holding Co., Ltd. a Buy or a Sell?

ASE Technology Holding Co., Ltd. stock is rated a Buy

The current ASE Technology Holding Co., Ltd. [ASX] share price is $15.16. The Score for ASX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.